Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LJ5Q
|
|||
| Former ID |
DNCL003214
|
|||
| Drug Name |
GSK2340274A
|
|||
| Indication | Influenza A virus H1N1/H5N1 infection [ICD-11: 1E30] | Phase 4 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01114620) Study of GSK Biologicals' Influenza Vaccine Arepanrix in Japanese Adults 65 Years of Age or Older. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.